DJ Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ advanced 1.57% to $20.07 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.07% to 22,333.96 and Dow Jones Industrial Average falling 0.27% to 45,757.90.
The stock's rise snapped a two-day losing streak.
Catalyst Pharmaceuticals Inc. closed 24.49% short of its 52-week high of $26.58, which the company reached on June 9th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 0.53% to $176.46, Pfizer Inc. $(PFE)$ fell 0.29% to $23.90, and Abbott Laboratories $(ABT)$ rose 1.09% to $132.76.
Trading volume (1.5 M) remained 20,133 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 16, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 16, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.